This inventor holds 3 USPTO granted patents and 7 published patent applications. Top assignee: Tygrus, LLC. Active years: 2023-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2024
Title: Andrew M. Yaksic: Innovator in Respiratory Treatment
Introduction
Andrew M. Yaksic is a notable inventor based in Brighton, MI, with a strong focus on developing innovative therapeutic solutions for respiratory illnesses. With three patents to his name, his contributions to the field of medicine are particularly significant, especially in addressing urgent health concerns like COVID-19. Working at Tygrus, LLC, Andrew has collaborated with other talented individuals to push the boundaries of medical treatment.
Latest Patents
Andrew's latest patents include a groundbreaking method and composition for treating or preventing respiratory illnesses. This invention features a therapeutic material with low pH and low toxicity that is active against various pathogens. The method involves administering at least one dose of a pharmaceutically acceptable fluid, having a pH of less than 3.0, into the respiratory tract of patients in need. This innovative approach has the potential to treat respiratory illnesses, including COVID-19.
Career Highlights
Over his career, Andrew has made significant strides in medical research and development. His patents reflect a commitment to improving patient care and finding effective treatments for serious health conditions. His work at Tygrus, LLC has allowed him to apply his expertise in creating viable and impactful medical solutions.
Collaborations
At Tygrus, LLC, Andrew collaborates with skilled professionals including Paul A. Bundschuh and Lawrence R. Carlson. This teamwork fosters an environment of innovation and creativity, allowing for new ideas and solutions to emerge in the healthcare landscape.
Conclusion
Andrew M. Yaksic's innovative work in the realm of respiratory treatments demonstrates his commitment to enhancing patient outcomes. Through his patents and collaborations at Tygrus, LLC, he is paving the way for promising methodologies that hold the potential to change lives. His contributions embody the spirit of innovation and the dedication of inventors who work tirelessly to address critical health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile